1. Home
  2. IMUX vs FGBI Comparison

IMUX vs FGBI Comparison

Compare IMUX & FGBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunic Inc.

IMUX

Immunic Inc.

BUY

Current Price

$8.09

Market Cap

155.8M

Sector

Health Care

ML Signal

BUY

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

BUY

Current Price

$8.39

Market Cap

134.1M

Sector

Finance

ML Signal

BUY

Company Overview

Basic Information
Metric
IMUX
FGBI
Founded
2016
1934
Country
United States
United States
Employees
66
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
155.8M
134.1M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
IMUX
FGBI
Price
$8.09
$8.39
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $43.09
N/A
AVG Volume (30 Days)
★ 394.8K
13.7K
Earning Date
11-12-2026
11-16-2026
Dividend Yield
N/A
★ 0.48%
EPS Growth
★ 38.00
N/A
EPS
N/A
★ 0.31
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$26.42
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$4.31
52 Week High
$17.43
$11.02

Technical Indicators

Market Signals
Indicator
IMUX
FGBI
Relative Strength Index (RSI) 24.90 55.95
Support Level $0.78 $8.24
Resistance Level $15.82 $8.87
Average True Range (ATR) 0.70 0.35
MACD -0.10 0.06
Stochastic Oscillator 9.78 90.48

Price Performance

Historical Comparison
IMUX
FGBI

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana through several banking facilities. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and, to a lesser extent, consumer and multifamily loans. The company is engaged in a single line of business as a financial institution, which provides a full range of banking, financial, and trust services to state, county, and local government entities, individuals, and small and commercial businesses.

Share on Social Networks: